The ability of SHP2 inhibition in tumor cells to prevent the ability of growth factors to protect tumor cells from T cell–mediated killing was confirmed by doxycycline-inducible depletion of SHP2 (Supplementary Fig. S13C and S13D). This evidence concerns the gene PTPN11 and neoplasm.